Type 2 Myocardial Infarction-Diagnosis, Prognosis, and Treatment

JAMA. 2018 Aug 7;320(5):433-434. doi: 10.1001/jama.2018.7125.

Authors

Cian P McCarthy¹, Muthiah Vaduganathan², James L Januzzi Jr^{3

4}

Affiliations

¹ Department of Medicine, Massachusetts General Hospital, Boston.
² Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, Massachusetts.
³ Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston.
⁴ Cardiometabolic Trials Baim Institute for Clinical Research, Boston, Massachusetts.

PMID: 29889937
DOI: 10.1001/jama.2018.7125

No abstract available

MeSH terms

Anticoagulants / therapeutic use
Biomarkers / blood
Coronary Artery Disease / complications
Coronary Artery Disease / therapy
Humans
Myocardial Infarction / classification*
Myocardial Infarction / diagnosis
Myocardial Infarction / mortality
Myocardial Infarction / therapy
Myocardial Revascularization
Prognosis

Substances

Anticoagulants
Biomarkers